Projected Device M&A Rebound Leaves VCs Breathing Easier
This article was originally published in The Gray Sheet
U.S. merger and acquisition activity in the medical device sector is set for a rebound this year as the stock market stabilizes after a weak 2002, according to Deutsche Bank Managing Director of West Coast Health Care Investment Banking Michael Cohen
You may also be interested in...
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.
C&D CEO Matthew Farrell says Zicam has 73% share in the US zinc-containing wellness product market. It's acquiring marketer Matrixx Initiatives at a price almost 15 times Zicam brand’s projected 2021 EBITDA.